Marshall Goldsmith

FEBRUARY 8, 2018

Co-founder of Rose Park Advisors—Disruptive Innovation Fund. A leading thinker on strategy and breakthrough innovation. Tony Marx – President and CEO, New York Public Library – the nation’s largest library system. Previously Kevin was a leader in Electronic Data Systems and Ford. Former President, Amherst College.

Executive Coaching 70

Executive Coaching CEO Magazine Banking 70

Harvard Business Review

JULY 8, 2016

China has not been a huge technology innovator, despite being the world’s second-largest investor in R&D , but Chinese businesses have found ways to use innovations in processes, business models, and customer experience to their disruptive advantage. This presents Western companies with a fresh challenge.

Business Model 10

Business Model Innovation Company Apparel 10

Harvard Business Review

DECEMBER 14, 2017

health care system is begging for disruption. Combining an insurance function with a delivery system has ample precedent in health care. Some of the nation’s most innovative, high-performing non-profit health care organizations use this formula. Paul Taylor/Getty Images. It costs way too much ($3.3

Health Care 8

Health Care System Insurance Pharmaceuticals 8

Strategy Driven

NOVEMBER 29, 2016

When it’s time to hire for critical positions within your company, consider the training and certification in military systems offered to service men and women.

Agility 50

Agility Pharmaceuticals Self-aware Crisis Management 50

Harvard Business Review

SEPTEMBER 15, 2011

patent system in over half a century. Supporters of the new measure argue that it will streamline the patent application process and harmonize America's system with the rest of the world, and it will allow for more rapid approval and increased certainty in the validity of patents. They haven't.

Innovation 12

Innovation Chemicals Incentives Pharmaceuticals 12

Harvard Business Review

SEPTEMBER 21, 2018

Corporate directors and executives alike recognize that today’s pace of change continues to accelerate and that firms need to innovate to stay ahead. But are boards doing enough to support innovation, as they should? We found that, overall, innovation does not rank as a top strategic challenge for the majority of boards.

Innovation 10

Innovation Short-term Telecommunications Long-term 10

Harvard Business Review

JUNE 26, 2014

In his 2008 book Patent Failure , Bessen and co-author Michael Meurer argue that after taking the cost of litigation into account, the effect of patenting in all industries except pharmaceuticals and chemicals was to reduce the profitability of innovation rather than to increase it. Innovation Technology'

Innovation 9

Innovation Pharmaceuticals Chemicals Software 9

Harvard Business Review

FEBRUARY 22, 2011

Editor's note: This post is the first in a three-week series examining innovation in health care, published in partnership with the Advanced Leadership Initiative at Harvard University. Lack of consensus among players in a complex system is one of the biggest barriers to innovation. It's a classic change management problem.

Health Care 15

Health Care Innovation Pharmaceuticals Consensus 15

Coaching Tip

MARCH 15, 2011

Nothing has ever been able to keep it down for long, and nothing ever will, if we are patient and allow our economy the time to heal itself through the virtues of the free-market system. . All it takes is the desire to be innovative and creative in tackling a problem. Deregulation. Entrepreneurship.

Pharmaceuticals 84

Pharmaceuticals Creativity Long-term Power 84

Harvard Business Review

JANUARY 27, 2016

Much fanfare has been paid to the term “disruptive innovation” over the past few years. Disruptive innovations are: Cheaper (from a customer perspective). New technologies, combined with business model innovation, provide the structural cost advantage necessary to take large chunks of the market over time.

Disruptive Innovation 8

Disruptive Innovation Innovation Short-term Long-term 8

Harvard Business Review

OCTOBER 29, 2012

If the cost of innovation is falling, that should enable more of it from poorer countries, companies or cooperatives. If it's not, the already big and already rich will dominate innovation. Some of this may just be the product of the high regulatory costs in pharmaceuticals, but research by Harvard's F.M.

Cost 8

Cost Innovation Wireless Disruptive Innovation 8

Harvard Business Review

MARCH 28, 2012

The Swiss pharmaceutical giant Roche is nothing if not determined in its quest to acquire Illumina, the San Diego-based leader in genetic-sequencing equipment. An acquirer looking for innovation would have been likelier to try to buy Gateway, a company that is almost an after-thought now. billion tender offer directly to shareholders.

Innovation 13

Innovation Company Biotechnology CFO 13

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. Besides Dr Reddy's, several leading Indian firms are pioneering polycentric innovation: Tata Motors. Polycentric innovation won't work in organizations that promote groupthink. Cambridge, U.K. Reliance MediaWorks.

Globalization 9

Globalization Innovation Decentralization Chemicals 9

First Friday Book Synopsis

MARCH 21, 2012

An entrepreneur and veteran of the computer industry, Frank Moss spent his career bringing innovative technologies to market. Ten years ago he set out to make a broader contribution to the world, leading him to cofound a cancer drug discovery company and then to the MIT Media Lab, where he served as director from 2006 [.].

Entrepreneur 80

Entrepreneur Media Technology Innovation 80

Harvard Business Review

MAY 7, 2015

The convergence of mobile, analytics, context-rich systems, and the cloud, together with an explosion of information, is transforming sales, and enabling buyers and salespeople to engage with each other in more effective and efficient ways. Context rich systems. Cloud Computing and 5.

Trends 8

Trends Technology Pharmaceuticals Team 8

Harvard Business Review

MARCH 18, 2018

Why the Pharmaceutical Industry Is Booming in Japan. This also includes innovative systems for patient-requested care, promotion of self-medication, cloud-based record availability, and remote monitoring of patients in their homes. Conditional early approval expanded to cover innovative medical devices in July 2017.

Health Care 8

Health Care Industry Pharmaceuticals Content 8

Harvard Business Review

JUNE 9, 2017

How the most innovative providers are creating value. Clinicians working for medical centers or health systems can be in conflict of interest without receiving money from industry. From these experiences, we believe that conflict-of-interest policies governing interactions in three areas need to be revamped. Insight Center.

Conflict of Interest 10

Conflict of Interest Pharmaceuticals Policies Industry 10

Harvard Business Review

OCTOBER 26, 2017

“The medieval guild system was a primitive networking exercise.” “He that will not apply new remedies must expect new evils; for time is the greatest innovator,” stated Francis Bacon. The major innovation lay in an extraordinary machine already in use in Lucca, about 150 kilometers southwest of Bologna.

Education 8

Education Pharmaceuticals Innovation Industry 8

Harvard Business Review

MARCH 1, 2011

Editor's note: This post is part of a three-week series examining innovation in health care, published in partnership with the Advanced Leadership Initiative at Harvard University. And that's true in many areas: New devices, pharmaceuticals, and surgical techniques regularly get developed and incorporated into practice.

Health Care 15

Health Care Biotechnology Mayo Pharmaceuticals 15

Strategy Driven

MARCH 18, 2011

Further, they need to limit their focus to, at most, six capabilities, and make those capabilities work together as a mutually reinforcing system that perpetuates competitive advantage. That belief stems from having chosen a differentiated way to play that is supported by a strong system of mutually reinforcing capabilities.

Resources 52

Resources Industry System Strategy 52

Harvard Business Review

OCTOBER 23, 2014

That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. Think of it as a 360-degree/24-7 support system. They’re also sharing risk. The new business model has yet to solidify, and the leaders have yet to emerge. But not for long.

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

Harvard Business Review

FEBRUARY 17, 2011

Venture capitalists are increasingly interested in emerging markets, and in working with local funds based in those markets (despite the fact that reverse innovation in venture capital seems counterintuitive). In effect, the VCs at Nadathur Holdings serve as the executive team for a miniature healthcare innovation ecosystem.

Marketing 15

Marketing Venture Capitalist Biotechnology IPO 15

Harvard Business Review

APRIL 2, 2018

health care system woefully underperform relative to those made in health care in other countries. To be sure, many factors influence health outcomes and the investments the health care system makes are only one input. Yet, investments in the U.S. For instance, the U.S. For instance, the U.S.

Health Care 8

Health Care Insurance Pharmaceuticals Incentives 8

Harvard Business Review

JULY 4, 2017

Tim Cook recently confirmed that Apple is working on ‘autonomous systems.’ The third playbook for an Apple vehicle is to create new categories , via breakthrough product innovation and breakthrough business model innovation. What parent who could afford it wouldn’t pay a premium for a car like this?

Transportation 10

Transportation Sports Pharmaceuticals Health Care 10

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

DECEMBER 18, 2014

It used to be that hospitals and health systems operated as islands, selecting and purchasing medical supplies, devices and medications in isolation, and keeping their operational and leadership practices to themselves. Those numbers yield a very different type of supplier/customer conversation.

Health Care 8

Health Care Retail Mayo Pharmaceuticals 8

Harvard Business Review

OCTOBER 7, 2014

The lesson: Frontline people can not only help the top leader validate an innovative new strategy, they can also be a powerful means to convince customers and those in higher levels at your company to buy in. . One day he observed a pharmaceuticals sales rep stop the car and run into a Costco for a few minutes.

CEO 11

CEO Strategy Pharmaceuticals B2B 11

Harvard Business Review

FEBRUARY 4, 2013

How easy is it to change a flawed economic or governance system, such as our current 1.5-planets-and-counting We'd see more corporate social responsibility, socially responsible investing and sustainability reporting, but overall the outcome would be little more than a set of patches on the existing, dysfunctional system.

EPS 8

EPS Innovation CEO Pharmaceuticals 8

Harvard Business Review

OCTOBER 13, 2011

A better understanding of the drivers of behavior is needed for both banks and consumers to understand risk, and for the financial system to provide timely and targeted interventions. The pharmaceutical industry also creates products with complex interactions and potentially dangerous side effects.

Banking 10

Banking Pharmaceuticals Microfinance Risk Management 10

Harvard Business Review

JUNE 27, 2012

Paul is an old friend who, until his recent retirement, worked as a senior scientist at a pharmaceutical company, where he managed a group of innovative researchers. Some good scientists left the company, and others lost their innovative spark. If this homogenization had worked, it might well have spelled disaster.

COO 11

COO Short-term Pharmaceuticals Innovation 11

Harvard Business Review

OCTOBER 22, 2013

Innovation starts with new and novel ideas. When we surveyed over 300 global executives between 2008 and 2009, one of the primary concerns they expressed was their inability to compete long term without a solid innovation engine that can grow their top line. Everything, everyone, and every system evolves over time. Find Pivots.

Skills 8

Skills Power Six Sigma Disruptive Innovation 8

Harvard Business Review

MARCH 11, 2013

Apple is probably the most successful and innovative company on earth over the past decade, and it's extremely closed and secretive. But such opacity does not derive from some inherent benefits of closed work systems. The open work systems within Google, for example show how full collaboration within an enterprise pays off.

Supply Chain 15

Supply Chain Open-book Software Niche Marketing 15

Harvard Business Review

FEBRUARY 2, 2015

Steel did in an earlier era of manufacturing, Aquion and innovative firms like it are spearheading economic and employment growth across the country. Indeed, in a world where globalization and rapid technological changes are the norm, manufacturing, high-tech development, and innovation clearly require a different level of support.

Industry 8

Industry McKinsey Engineering Innovation 8

Harvard Business Review

AUGUST 14, 2018

Google, for example, has succeeded in dominating many foreign markets that have radically different political systems and cultures (including Indonesia, Thailand, and Saudi Arabia). ineffective innovation strategies. 5 Principles for Innovation in Emerging Markets. failure to fully embed operations in China. Related Video.

Competitive Advantage 11

Competitive Advantage Business Model Technology Marketing 11

Harvard Business Review

MAY 8, 2013

I recently conducted a study of 56 randomly selected companies involved in major change and innovation efforts in the high-tech, retail, pharmaceutical, banking, automotive, insurance, energy, non-profit, and health care industries. Nearly 68% of these large-scale change and innovative efforts failed.

Middle Management 9

Middle Management Management Automotive Pharmaceuticals 9

Harvard Business Review

DECEMBER 5, 2016

Library leaders knew that given the immense changes brought on by digital innovations, as well as shifts in the communities that the Library served, it would need to evolve. Innovation communities had been used by Best Buy to grow its portion of the women’s consumer electronics market by $4.4b in less than five years.

Library 8

Library Strategy Reference Bottom-up 8

Harvard Business Review

JANUARY 31, 2013

Second, we see a raft of innovations that will alter how products are designed, manufactured and sold — everything from nanotechnologies to 3D printing. Then, manufacturing's most important role is as a driver of innovation, trade, and productivity. Innovations Are Changing The Way We Design Products.

Globalization 9

Globalization Supply Chain Pharmaceuticals McKinsey 9